Triple-combo Drug Shows Promise Against Antiviral-resistant H1N1
University of Alabama at BirminghamAn experimental drug cocktail that includes three prescriptions now widely available offers the best hope in developing a single agent to treat drug-resistant H1N1 swine flu, says a UAB virology researcher. The combo of oseltamivir, amantadine and ribavirin drug works better than currently recommended single or double antiviral therapies used to treat both seasonal and swine flu strains.